Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LNPEP | Q9UIQ6 | 5/20 | 0.58 |
| ▸ | REN | P00797 | 12/20 | 0.54 |
| ▸ | ANPEP | P15144 | 1/20 | 0.51 |
| ▸ | CTSD | P07339 | 1/20 | 0.50 |
| ▸ | TRHR | P34981 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29636378 | 0.90 | LNPEP (0.54) | LNPEPRENANPEPCTSD | |
| SCHEMBL19345095 | 0.82 | TRHR (0.61) | LNPEPRENCTSDTRHR | |
| SCHEMBL30661445 | 0.82 | ACE (0.47) | REN | |
| SCHEMBL30661449 | 0.82 | ACE (0.47) | REN | |
| SCHEMBL30051606 | 0.82 | ACE (0.49) | REN | |
| SCHEMBL30253567 | 0.81 | LNPEP (0.76) | LNPEPRENANPEP | |
| SCHEMBL31435690 | 0.80 | REN (0.58) | RENCTSDTRHR | |
| SCHEMBL4959538 | 0.79 | TRHR (0.64) | LNPEPRENCTSDTRHR | |
| SCHEMBL30498898 | 0.79 | CAPN1 (0.49) | REN | |
| SCHEMBL21838312 | 0.79 | SLC15A2 (0.54) | LNPEPRENANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090036363-A1 | Peptides as cell penetrating carriers | UNIVERSIDAD DE BARCELONA (ES) | 2009-02-05 | — | — | US | disclosed |
| EP-1724280-A1 | USE OF PEPTIDES AS PENETRATING CELL CARRIERS | UNIVERSIDAD DE BARCELONA (ES) | 2006-11-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036363-A1 | Peptides as cell penetrating carriers | ARGLU1, SLC7A1, ARG1 | LNPEP 7/4885REN 2209/4885ANPEP 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.